《復牌公告》海藍控股(02278.HK)獲大股東溢價5%提全購
海藍控股(02278.HK)今日(8日)復牌。公司公布,持有公司75%股權的控股股東楊敏擬以現金要約的方式向公司提全購,每股要約股份為3.36元,較上周五(5日)收市價3.2元溢價約5%。要約股份總數將為7,500萬股,涉及應付總代價約2.52億元。
完成後,公司將成為要約人的直接全資附屬,並將根據上市規則申請撤回股份於聯交所的上市地位。
公司指出,由於公司股份交易的流動性較低,公司目前在聯交所的上市地位不再為公司業務及增長提供充足的資金來源。撤回上市地位的可能性將使要約人有更大的靈活性,以支持集團未來業務發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.